Back
Praxis Precision Medicines Vs. Protagonist Therapeutics Industry Stock Comparison
Buy
67
PRAX
Praxis Precision Medicines
Last Price:
77.92
Seasonality Move:
72.55%
Sell
44
PTGX
Protagonist Therapeutics
Last Price:
46.23
Seasonality Move:
17.94%
Buy
67
Praxis Precision Medicines (PRAX)
is a Buy
Is Praxis Precision Medicines a Buy, Sell or Hold?
- The current Praxis Precision Medicines [PRAX] share price is $77.88. The Score for PRAX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- PRAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $46.23. The Score for PTGX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRAX Stock Price Chart
What is Praxis Precision Medicines's stock price today?
-
The Praxis Precision Medicines share price today is $77.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $46.23
The current trend is moderately bearish and PTGX is experiencing slight selling pressure.
PRAX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.86 | Buy |
| Relative Strength Index (14 RSI): | 69.15 | Buy |
| Chaikin Money Flow: | 303234 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.98 - 74.06) | Buy |
| Bollinger Bands (100): | (47.44 - 66.8) | Buy |
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.51 | Buy |
| Relative Strength Index (14 RSI): | 49.55 | Sell |
| Chaikin Money Flow: | -305731 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (44.9 - 47.66) | Sell |
| Bollinger Bands (100): | (36.47 - 46.23) | Buy |
PRAX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.03 | Buy |
| 20-day SMA: | 71.65 | Buy |
| 50-day SMA: | 64.25 | Buy |
| 200-day SMA: | 52.71 | Buy |
| 8-day EMA: | 73.26 | Buy |
| 20-day EMA: | 70.68 | Buy |
| 50-day EMA: | 65.34 | Buy |
| 200-day EMA: | 52.46 | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.79 | Sell |
| 20-day SMA: | 46.86 | Sell |
| 50-day SMA: | 45.44 | Buy |
| 200-day SMA: | 34.97 | Buy |
| 8-day EMA: | 46.86 | Sell |
| 20-day EMA: | 46.57 | Sell |
| 50-day EMA: | 44.92 | Buy |
| 200-day EMA: | 36.32 | Buy |
Praxis Precision Medicines Earnings Growth & PRAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.19 per share, and a decrease next year of $1.62 per share.
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.99 per share, and a decrease next year of $3.26 per share.
Praxis Precision Medicines Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Protagonist Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||